592 related articles for article (PubMed ID: 21764271)
1. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies.
Zhu L; Ma J; Jia N; Zhao Y; Shen H
Colloids Surf B Biointerfaces; 2009 Jan; 68(1):1-6. PubMed ID: 19013060
[TBL] [Abstract][Full Text] [Related]
4. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
5. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
Tahara K; Kato Y; Yamamoto H; Kreuter J; Kawashima Y
J Microencapsul; 2011; 28(1):29-36. PubMed ID: 21171814
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
Amjadi I; Rabiee M; Hosseini MS; Mozafari M
Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
Lin R; Shi Ng L; Wang CH
Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
[TBL] [Abstract][Full Text] [Related]
8. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
Li Z; Qiu L; Chen Q; Hao T; Qiao M; Zhao H; Zhang J; Hu H; Zhao X; Chen D; Mei L
Acta Biomater; 2015 Jan; 11():137-50. PubMed ID: 25242647
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents.
Manchanda R; Fernandez-Fernandez A; Nagesetti A; McGoron AJ
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):260-7. PubMed ID: 19775872
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
[TBL] [Abstract][Full Text] [Related]
12. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
13. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer.
Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
Biomaterials; 2012 Aug; 33(22):5574-83. PubMed ID: 22579235
[TBL] [Abstract][Full Text] [Related]
15. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D,L-lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets.
Du L; Jin Y; Zhou W; Zhao J
Ultrasound Med Biol; 2011 Aug; 37(8):1252-8. PubMed ID: 21683513
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods.
Tewes F; Munnier E; Antoon B; Ngaboni Okassa L; Cohen-Jonathan S; Marchais H; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Eur J Pharm Biopharm; 2007 Jun; 66(3):488-92. PubMed ID: 17433641
[TBL] [Abstract][Full Text] [Related]
19. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
[TBL] [Abstract][Full Text] [Related]
20. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
Misra R; Sahoo SK
Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
